$240 Million is the total value of DAFNA Capital Management LLC's 80 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 25.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | $41,315,000 | -42.9% | 13,680,554 | 0.0% | 17.24% | -30.6% | |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $13,339,000 | +35.1% | 228,089 | +85.1% | 5.57% | +64.3% |
| FATE | FATE THERAPEUTICS INC | $10,439,000 | +13.5% | 470,000 | 0.0% | 4.36% | +38.0% | |
| GLPG | Sell | GALAPAGOS NVspon adr | $9,086,000 | -6.5% | 46,375 | -1.3% | 3.79% | +13.6% |
| DXCM | Sell | DEXCOM INC | $8,977,000 | +12.9% | 33,338 | -8.3% | 3.75% | +37.3% |
| ATRC | Sell | ATRICURE INC | $8,052,000 | -22.3% | 239,729 | -24.8% | 3.36% | -5.5% |
| IBB | Buy | ISHARES TR NASDAQ BIOTECHetf | $7,854,000 | +0.4% | 72,900 | +12.3% | 3.28% | +22.1% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $7,545,000 | +67.9% | 179,642 | +81.6% | 3.15% | +104.1% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $6,942,000 | +5.9% | 80,208 | +31.5% | 2.90% | +28.7% |
| PRQR | Buy | PROQR THERAPEUTICS N V | $6,793,000 | -38.5% | 1,237,400 | +11.1% | 2.84% | -25.2% |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $6,470,000 | +32.9% | 853,538 | +10.8% | 2.70% | +61.5% |
| LMNX | LUMINEX CORP | $5,619,000 | +18.9% | 204,091 | 0.0% | 2.34% | +44.5% | |
| CARA | Buy | CARA THERAPEUTICS INC | $4,901,000 | -7.4% | 371,033 | +12.9% | 2.04% | +12.5% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $4,748,000 | -47.3% | 165,306 | +32.5% | 1.98% | -36.0% |
| CGEN | New | COMPUGEN LTDord | $4,356,000 | – | 600,000 | +100.0% | 1.82% | – |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $3,961,000 | -38.8% | 293,440 | +9.6% | 1.65% | -25.6% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $3,930,000 | +20.5% | 346,535 | +39.3% | 1.64% | +46.4% |
| CRBP | Buy | CORBUS PHARMACEUTICALS HLDGS | $3,916,000 | +141.3% | 747,300 | +151.4% | 1.63% | +193.4% |
| AGTC | Buy | APPLIED GENETIC TECHNOL CORP | $3,808,000 | +134.5% | 1,160,878 | +223.2% | 1.59% | +185.3% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $3,799,000 | -2.8% | 33,737 | +20.1% | 1.58% | +18.1% |
| ALEC | Buy | ALECTOR INC | $3,740,000 | +49.7% | 155,000 | +6.9% | 1.56% | +82.1% |
| ZGNX | Buy | ZOGENIX INC | $3,543,000 | -36.3% | 143,249 | +34.2% | 1.48% | -22.6% |
| MRTX | New | MIRATI THERAPEUTICS INC | $3,236,000 | – | 42,102 | +100.0% | 1.35% | – |
| BHVN | Buy | BIOHAVEN PHARMACEUTICALS HOLD | $3,083,000 | -24.2% | 90,600 | +21.3% | 1.29% | -7.8% |
| KURA | Buy | KURA ONCOLOGY INC | $3,060,000 | +28.3% | 307,541 | +77.3% | 1.28% | +55.9% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $2,828,000 | -16.7% | 4,000,000 | 0.0% | 1.18% | +1.3% | ||
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $2,714,000 | +4.1% | 147,714 | +24.8% | 1.13% | +26.6% |
| AXGT | New | AXOVANT GENE THERAPIES LTD | $2,493,000 | – | 1,021,566 | +100.0% | 1.04% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $2,341,000 | +277.0% | 401,619 | +270.3% | 0.98% | +358.7% |
| KDMN | Buy | KADMON HOLDINGS INC | $2,332,000 | +37.5% | 556,564 | +48.6% | 0.97% | +67.2% |
| BEAT | Buy | BIOTELEMETRY INC | $2,330,000 | -9.0% | 60,500 | +9.4% | 0.97% | +10.6% |
| VKTX | Buy | VIKING THERAPEUTICS INC | $2,110,000 | +25.7% | 450,900 | +115.5% | 0.88% | +53.0% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $2,095,000 | +10.6% | 46,908 | +54.3% | 0.87% | +34.5% |
| CSII | Buy | CARDIOVASCULAR SYSTEMS INC | $1,803,000 | -19.7% | 51,200 | +10.8% | 0.75% | -2.5% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $1,797,000 | +308.4% | 234,952 | +850.3% | 0.75% | +396.7% |
| AFMD | Sell | AFFIMED NV | $1,791,000 | -42.3% | 1,133,401 | -0.0% | 0.75% | -29.9% |
| HARP | New | HARPOON THERAPEUTICS INC | $1,708,000 | – | 147,468 | +100.0% | 0.71% | – |
| EPZM | Buy | EPIZYME INC | $1,643,000 | -1.8% | 105,900 | +55.7% | 0.69% | +19.5% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $1,448,000 | +16.3% | 54,054 | +33.0% | 0.60% | +41.5% |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $1,317,000 | -0.2% | 219,800 | +119.8% | 0.55% | +21.4% |
| ARAY | ACCURAY INC | $1,281,000 | -32.6% | 674,300 | 0.0% | 0.54% | -18.1% | |
| JNJ | JOHNSON AND JOHNSON | $1,233,000 | -10.1% | 9,400 | 0.0% | 0.52% | +9.3% | |
| INGN | INOGEN INC | $1,188,000 | -24.4% | 23,000 | 0.0% | 0.50% | -8.1% | |
| BLUE | BLUEBIRD BIO INC | $1,172,000 | -47.6% | 25,500 | 0.0% | 0.49% | -36.3% | |
| ZYME | New | ZYMEWORKS INC | $1,135,000 | – | 32,000 | +100.0% | 0.47% | – |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $1,061,000 | -51.8% | 320,542 | -11.1% | 0.44% | -41.4% |
| ARDX | Sell | ARDELYX INC | $1,051,000 | -29.9% | 184,850 | -7.5% | 0.44% | -14.8% |
| NTUS | NATUS MEDICAL INC | $992,000 | -29.9% | 42,900 | 0.0% | 0.41% | -14.8% | |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $958,000 | -46.0% | 479,051 | -6.8% | 0.40% | -34.3% |
| STIM | Buy | NEURONETICS INC | $937,000 | -47.3% | 495,772 | +25.3% | 0.39% | -35.9% |
| GNCA | GENOCEA BIOSCIENCES INC | $933,000 | -16.9% | 542,564 | 0.0% | 0.39% | +1.0% | |
| OTIC | OTONOMY INC | $924,000 | -48.6% | 469,135 | 0.0% | 0.39% | -37.4% | |
| PRVL | PREVAIL THERAPEUTICS INC | $914,000 | -23.0% | 75,000 | 0.0% | 0.38% | -6.4% | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $908,000 | -26.7% | 13,600 | 0.0% | 0.38% | -10.8% | |
| MGNX | MACROGENICS INC | $873,000 | -46.5% | 150,000 | 0.0% | 0.36% | -35.0% | |
| SYBX | SYNLOGIC INC | $861,000 | -33.4% | 500,731 | 0.0% | 0.36% | -19.0% | |
| CTMX | CYTOMX THERAPEUTICS INC | $767,000 | -7.7% | 100,000 | 0.0% | 0.32% | +12.3% | |
| NXTC | NEXTCURE INC | $741,000 | -34.3% | 20,000 | 0.0% | 0.31% | -20.2% | |
| ARCT | Sell | ARCTURUS THERAPEUTICS HLDG I | $715,000 | -62.2% | 52,586 | -69.8% | 0.30% | -54.1% |
| DEXCOM INCnote 0.750% 5/1 | $687,000 | +23.6% | 250,000 | 0.0% | 0.29% | +50.3% | ||
| TCRR | New | TCR2 THERAPEUTICS INC | $610,000 | – | 78,786 | +100.0% | 0.26% | – |
| ARGX | Sell | ARGENX SEsponsored adr | $589,000 | -39.6% | 4,471 | -26.4% | 0.25% | -26.6% |
| MORF | MORPHIC HOLDING INC | $543,000 | -14.5% | 37,000 | 0.0% | 0.23% | +4.1% | |
| MASI | MASIMO CORPORATION | $531,000 | +12.0% | 3,000 | 0.0% | 0.22% | +36.2% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $528,000 | -27.5% | 35,573 | 0.0% | 0.22% | -12.0% | |
| GMDA | GAMIDA CELL LTD | $449,000 | -29.8% | 148,781 | 0.0% | 0.19% | -15.0% | |
| KRTX | New | KARUNA THERAPEUTICS INC | $449,000 | – | 6,231 | +100.0% | 0.19% | – |
| STRO | SUTRO BIOPHARMA INC | $408,000 | -7.3% | 40,000 | 0.0% | 0.17% | +12.6% | |
| XCUR | EXICURE INC | $407,000 | -48.3% | 275,000 | 0.0% | 0.17% | -37.0% | |
| SPRO | New | SPERO THERAPEUTICS INC | $389,000 | – | 48,103 | +100.0% | 0.16% | – |
| RCUS | New | ARCUS BIOSCIENCES INC | $386,000 | – | 27,798 | +100.0% | 0.16% | – |
| ELOX | Sell | ELOXX PHARMACEUTICALS INC | $375,000 | -75.2% | 191,494 | -7.0% | 0.16% | -70.0% |
| GRTS | GRITSTONE ONCOLOGY INC | $291,000 | -35.2% | 50,000 | 0.0% | 0.12% | -21.4% | |
| RDUS | RADIUS HEALTH INC | $286,000 | -35.6% | 22,000 | 0.0% | 0.12% | -21.7% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $246,000 | -27.0% | 157,700 | 0.0% | 0.10% | -11.2% | |
| ZFGN | ZAFGEN INC | $235,000 | -30.7% | 305,500 | 0.0% | 0.10% | -15.5% | |
| BTAI | New | BIOXCEL THERAPEUTICS INC | $103,000 | – | 4,614 | +100.0% | 0.04% | – |
| ASLN | Sell | ASLAN PHARMACEUTICALS LTDads | $88,000 | -63.2% | 86,082 | -26.9% | 0.04% | -54.9% |
| LCTX | LINEAGE CELL THERAPEUTICS IN | $79,000 | -7.1% | 95,000 | 0.0% | 0.03% | +13.8% | |
| URGN | Sell | UROGEN PHARMA LTD | $42,000 | -68.4% | 2,369 | -40.6% | 0.02% | -60.9% |
| EVLO | Exit | EVELO BIOSCIENCES INC | $0 | – | -10,726 | -100.0% | -0.02% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -36,960 | -100.0% | -0.10% | – |
| ADXS | Exit | ADVAXIS INC | $0 | – | -350,000 | -100.0% | -0.10% | – |
| INSM | Exit | INSMED INC | $0 | – | -30,000 | -100.0% | -0.25% | – |
| MLND | Exit | MILLENDO THERAPEUTICS INC | $0 | – | -129,525 | -100.0% | -0.30% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -1,207,413 | -100.0% | -0.38% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -179,845 | -100.0% | -0.50% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS | $0 | – | -438,884 | -100.0% | -0.91% | – |
| MNLO | Exit | MENLO THERAPEUTICS INC | $0 | – | -797,565 | -100.0% | -1.27% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -418,727 | -100.0% | -1.52% | – |
| ARQL | Exit | ARQULE INC | $0 | – | -497,762 | -100.0% | -3.41% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.